Quatrefolic® White Paper

Gnosis S.p.A., proprietary of the blockbuster ingredient Quatrefolic®, is proud to announce the publication of Quatrefolic® White Paper, a new tool to know more about this key ingredient and its powerful role in human health. Find out more

Subscribe to our newsletter!

By subscribing to our newsletter you will receive updates on the latest news about Quatrefolic® as well as articles and researches regarding folates. Subscribe!

Maternal folates and brain development

Newly results about association between prenatal folate status and children's brain anatomy have been showed in a research published in the British Journal of Nutrition in early 2016... Find out more

Positive List amendment

Following the Authority's favorable opinion the list of vitamin and mineral substances, set out in Annex II to Directive 2002/46/EC, has been officially amended to include Quatrefolic®, the glucosamine salt... Find out more

Legal notice Info cookieGNOSIS S.P.A. Sede Legale: Piazza del Carmine, 4 20121 Milano. P.IVA 02484720129 C.F. 10197170151 Cap. Soc 3.000.000,00 € i.v. Registro delle imprese N° 10197170151
Quatrefolic® is a registered trademark of Gnosis Spa

The statements on this web site have not been approved by the Food & Drug Administration. Our products are not intended to prevent, cure, treat, or diagnose any disease. Absolutely none of the statements on this web site should be construed as medical advice. We recommend all people consult a licensed health care professional before starting any dietary or exercise program.
By using our website you are consenting to our use of cookies in accordance with our Cookie Policy. Close